Medicine
Vancomycin 250 mg/5 mL oral solution
Vancomycin 250 mg/5 mL oral solution is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store at refrigerated conditions, 2° to 8°C (36° to 46°F). After mixing…
Key facts
- Active ingredient (INN)
- Vancomycin
- Brand
- Sold under the generic name
- Strength
- 250 mg/5 mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 80 mL, 300 mL, 150 mL
- Manufacturer
- Amneal Pharmaceuticals NY
- Origin register
- US FDA, United States
- Storage
- Store at refrigerated conditions, 2° to 8°C (36° to 46°F). After mixing, refrigerate and use within two weeks.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A07AA09 Vancomycin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 June 2023
- Identifiers
- RxCUI 2000134DailyMed set ID 3c47d5c4-8cdb-4701-8d7a-8a6e79025b53NDC 69238-2261Application ANDA215338
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 80 mL in 1 bottle | 69238-2261-3 | Amneal Pharmaceuticals NY | 26 June 2023 |
| 300 mL in 1 bottle | 69238-2261-5 | Amneal Pharmaceuticals NY | 26 June 2023 |
| 150 mL in 1 bottle | 69238-2261-7 | Amneal Pharmaceuticals NY | 26 June 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 April 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Vancomycin
Clinical summary
Vancomycin is a glycopeptide antibacterial indicated for the treatment of Clostridioides difficile -associated diarrhea, among other approved uses. It is available as powder for injection, injection and capsules for intravenous, oral and intravitreal use. MedsAcross supplies Vancomycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about VancomycinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- vancomycin hydrochloride prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Vancomycin 250 mg/5 mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.